The RORα agonist can increase the apoptosis of GC SGC7901 cells, while its reverse agonist SR3335 can reduce the 5-FU-mediated apoptosis, suggesting that RORα promotes the apoptosis of human gastric cancer cells [13]. Here, RORA is linked to gastric cancer.